AWH Aspira Women's Health: Bozor kapitallashuvining balans qiymatiga nisbati

Aspira Women's Health Inc (AWH) kompaniyasining rasmiy ramzlari

Biomeditsinaning gumanitar maqomi tufayli Aspira Women's Health barqaror geosiyosiy muhitda faoliyat yuritadi. GURU.Markets platformasida kompaniyaning kitob qiymatiga nisbatan narx koeffitsiyentini tahlil qilib, ushbu ko'rsatkich -0.53 darajasida mustahkamlanganini qayd etamiz. AWH raqobatlashish qobiliyati shaxsiy onkologik diagnostika algoritmlariga asoslangan, operatsion samaradorlik esa IT infratuzilmasi va foydalanuvchilarni qo'llab-quvvatlashning bulutli autsorsing xizmatlari orqali ta'minlanadi.

Aspira Women's Health Inc (AWH): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 26.04.2025gacha
Aspira Women's Health, Inc. asosiy tovari

Aspira Women's Health sug'urta qamrovini kengaytirish orqali innovatsion onkologik testlarning tijorat tatbiqini kengaytirmoqda. Ushbu ko'rsatkich biznesning joriy bozor qiymatini uning sof balans qiymati bilan solishtiradi. Ushbu koeffitsient aksiyalar kompaniyaning moddiy aktivlariga nisbatan qanchalik qimmat baholanganini aniqlaydi. Aktivlarning fundamental qiymati bozor tebranishlari paytida himoya to'sig'i vazifasini o'taydi. Bozor kapitalizatsiyasi va balans qiymati o'rtasidagi tarixiy bog'liqlikda ushbu parametrning tendentsiyasi investitsiyaning xavfsizlik zaxirasini baholash imkonini beradi.

Asosiy raqobatchilar

A (Agilent Technologies) - Bozor qiymatining balans qiymatiga nisbati|questdiagnostics.com (DGX) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ILMN (Illumina)|Bozor qiymatining balans qiymatiga koeffitsiyenti Exact Sciences Corp|Bozor kapitallashuvining balans qiymatiga nisbati PerkinElmer RVTY|Kapitallashuvning balans qiymatiga nisbati Bio-Rad Corp (BIO)|Bozor kapitallashuvining balans qiymatiga nisbati NNNN (Anbio Biotechnology)|soterahealth.com - Bozor kapitallashuvining balans qiymatiga nisbati|QuidelOrtho Corporation (QDEL) - Bozor qiymatining balans qiymatiga nisbati|OPK - Kapitallashuvning balans qiymatiga nisbati|CDNA: Bozor kapitallashuvining balans qiymatiga nisbati|MRVI (Maravai) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Fulgent Genetics, Inc.|Bozor qiymatining balans qiymatiga nisbati fluidigm.com (LAB)|Cytek Biosciences - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OSUR (OraSure Technologies, Inc.)|Bozor qiymatining balans qiymatiga nisbati XGN|Balans qiymatiga nisbatan bozor kapitallashuvi MDxHealth, Inc. MDXH|Bozor kapitallashuvining balans qiymatiga nisbati LUCD (Lucid Diagnostics Inc.)|PRE: Balans qiymatiga nisbatan bozor kapitallashuvi|imdxinc.com - Bozor qiymatining balans qiymatiga nisbati|Trinity Biotech (TRIB) - Balans qiymatiga nisbatan bozor kapitallashuvi|PRPH (ProPhase) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AIMD|CODX (Co-Diagnostics, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HSCS (heartsciences.com)|Biomerica (BMRA) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Cardio Diagnostics Holdings Inc. CDIO|Bozor kapitallashuvining balans qiymatiga nisbati VRAX (Virax Biolabs Group Ltd)|BJDX: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Accelerate Diagnostics AXDX|CENTOGENE (CNTG) - Balans qiymatiga nisbatan bozor qiymati|ENZ (Enzo Biochem Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Fresh2 (FRES)|Genetic Technologies (GENE) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati 23andMe Inc ME|Psychemedics - Kapitallashuvning sof aktivlarga nisbati